Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties

Protein Science

Volumn 21, Issue 12, 2012, Pages 1897-1910

  Olsson, Niclas ^a,b   Wallin, Stefan ^c   James, Peter ^a,b   Borrebaeck, Carl A K ^a,b   Wingren, Christer ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b CREATE Health   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Anti peptide antibody; Antibody specificity; Immunoaffinity peptide capture; Mass spectrometry; Peptide binding

Indexed keywords

EPITOPE; PROTEOME; RECOMBINANT ANTIBODY;

ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; EPITOPES; HUMANS; MASS SPECTROMETRY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SINGLE-CHAIN ANTIBODIES;

EUKARYOTA; MAMMALIA;

EID: 84870309091     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2173     Document Type: Article

References (41)

1. Neduva V, Linding R, Sφ-Angrand I, Stark A, de Masi F, Gibson TJ, Lewis J, Serrano L, Russell RB (2005) Systematic discovery of new recognition peptides mediating protein interaction networks. PLoS Biol 3:e405.
2. Petsalaki E, Russell RB (2008) Peptide-mediated interactions in biological systems: new discoveries and applications. Curr Opin Biotechnol 19:344-350.
3. Hancock RE, Nijnik A, Philpott DJ (2012) Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol 10:243-254.
4. Hanash SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452:571-579.
5. Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H, Zhao X, Vu BT, Qing W, Packman K, Myklebost O, Heimbrook DC, Vassilev LT (2006) Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci USA 103:1888-1893.
6. Karanicolas J, Kuhlman B (2009) Computational design of affinity and specificity at protein-protein interfaces. Curr Opin Struct Biol 19:458-463.
7. Ussar S, Vienberg SG, Kahn CR (2011) Receptor antibodies as novel therapeutics for diabetes. Sci Transl Med 3:113ps47.
8. Stanfield RL, Wilson IA (1995) Protein-peptide interactions. Curr Opin Struct Biol 5:103-113.
9. Wilson IA, Stanfield RL (1994) Antibody-antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol 4:857-867.
10. Pope ME, Soste MV, Eyford BA, Anderson NL, Pearson TW (2009) Anti-peptide antibody screening: selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique. J Immunol Methods 341:86-96.
11. Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823-836.
12. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
13. Li L, Wang B, Frelinger JA, Tisch R (2008) T-cell promiscuity in autoimmune diabetes. Diabetes 57:2099-2106.
14. Eisen HN (2001) Specificity and degeneracy in antigen recognition: yin and yang in the immune system. Annu Rev Immunol 19:1-21.
15. Markovic-Plese S (2009) Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis. Neuroscientist 15:225-231.
16. Mazza C, Auphan-Anezin N, Gregoire C, Guimezanes A, Kellenberger C, Roussel A, Kearney A, van der Merwe PA, Schmitt-Verhulst AM, Malissen B (2007) How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides? EMBO J 26:1972-83.
17. Cohn M (2008) An in depth analysis of the concept of " polyspecificity" assumed to characterize TCR/BCR recognition. Immunol Res 40:128-147.
18. Sethi DK, Agarwal A, Manivel V, Rao KV, Salunke DM (2006) Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity 24:429-438.
19. Kramer A, Keitel T, Winkler K, Stocklein W, Hohne W, Schneider-Mergener J (1997) Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody. Cell 91:799-809.
20. Keitel T, Kramer A, Wessner H, Scholz C, Schneider-Mergener J, Hohne W (1997) Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell 91:811-820.
21. Olsson N, Wingren C, Mattsson M, James P, O'Connell D, Nilsson F, Cahill DJ, Borrebaeck CAK (2011) Proteomic analysis and discovery using affinity proteomics and mass spectrometry. Mol Cell Proteomics 10:M110003962.
22. Wingren C, James P, Borrebaeck CAK (2009) Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics 9:1511-1517.
23. Olsson N, James P, Borrebaeck CAK, Wingren C (2012) Quantitative proteomics targeting classes of motif-containing peptides using immunoaffinity-based mass spectrometry. Mol Cell Proteomics 11:342-354.
24. Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, Clamp M, Clarke L, Coates G, Cox T, Cunningham F, Curwen V, Cutts T, Down T, Durbin R, Fernandez-Suarez XM, Gilbert J, Hammond M, Herrero J, Hotz H, Howe K, Iyer V, Jekosch K, Kahari A, Kasprzyk A, Keefe D, Keenan S, Kokocinsci F, London D, Longden I, McVicker G, Melsopp C, Meidl P, Potter S, Proctor G, Rae M, Rios D, Schuster M, Searle S, Severin J, Slater G, Smedley D, Smith J, Spooner W, Stabenau A, Stalker J, Storey R, Trevanion S, Ureta-Vidal A, Vogel J, White S, Woodwark C, Birney E (2005) Ensembl 2005. Nucleic Acids Res 33:D447-D453.
25. Li SS (2005) Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 390:641-653.
26. Ladbury JE, Arold S (2000) Searching for specificity in SH domains. Chem Biol 7:R3-R8.
27. Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, Wilson IA (1998) Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166-1172.
28. Reiser JB, Gregoire C, Darnault C, Mosser T, Guimezanes A, Schmitt-Verhulst AM, Fontecilla-Camps JC, Mazza G, Malissen B, Housset D (2002) A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16:345-354.
29. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, Burrows SR, McCluskey J, Rossjohn J (2003) A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18:53-64.
30. Knapp B, Giczi V, Ribarics R, Schreiner W (2011) PeptX: using genetic algorithms to optimize peptides for MHC binding. BMC Bioinformatics 12:241.
31. Ben-Shimon A, Eisenstein M (2010) Computational mapping of anchoring spots on protein surfaces. J Mol Biol 402:259-277.
32. Soderlind E, Strandberg L, Jirholt P, Kobayashi N, Alexeiva V, Aberg AM, Nilsson A, Jansson B, Ohlin M, Wingren C, Danielsson L, Carlsson R, Borrebaeck CAK (2000) Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol 18:852-856.
33. Hoeppe S, Schreiber TD, Planatscher H, Zell A, Templin MF, Stoll D, Joos TO, Poetz O (2011) Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification. Mol Cell Proteomics 10:M110 002857.
34. Planatscher H, Supper J, Poetz O, Stoll D, Joos T, Templin MF, Zell A (2010) Optimal selection of epitopes for TXP-immunoaffinity mass spectrometry. Algorithms Mol Biol 5:28.
35. Hakkinen J, Vincic G, Mansson O, Warell K, Levander F (2009) The proteios software environment: an extensible multiuser platform for management and analysis of proteomics data. J Proteome Res 8:3037-3043.
36. Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14:1188-1190.
37. Maupetit J, Derreumaux P, Tuffery P (2009) PEPFOLD: an online resource for de novo peptide structure prediction. Nucleic Acids Res 37:W498-W503.
38. Irback A, Mohanty S (2006) PROFASI: A Monte Carlo simulation package for protein folding and aggregation. J Comput Chem 27:1548-1555.
39. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714-2723.
40. de Hoon MJ, Imoto S, Nolan J, Miyano S (2004) Open source clustering software. Bioinformatics 20:1453-1454.
41. Mobley DL, Dill KA (2009) Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". Structure 17:489-498.